SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Brown Vance R

(Last) (First) (Middle)
300 BOSTON SCIENTIFIC WAY

(Street)
MARLBOROUGH MA 01752-1234

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/07/2021
3. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, GC and Corp. Secretary
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 27,436 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock Units (1) 02/15/2023(1) Common Stock 1,846(2) (3) D
Deferred Stock Units (4) 02/18/2024(4) Common Stock 2,223(5) (3) D
Deferred Stock Units (6) 02/21/2023(6) Common Stock 1,558(7) (3) D
Deferred Stock Units (8) 02/28/2022(8) Common Stock 1,019(9) (3) D
Deferred Stock Units (10) 10/02/2022(10) Common Stock 6,787(11) (3) D
Restricted Stock Units (12) 02/17/2025(12) Common Stock 4,000 (13) D
Stock Option (Right to Buy) (14) 02/28/2027 Common Stock 18,037 24.55 D
Stock Option (Right to Buy) (15) 02/15/2028 Common Stock 15,006 27.09 D
Stock Option (Right to Buy) (16) 02/17/2031 Common Stock 14,299 37.5 D
Stock Option (Right to Buy) (17) 02/21/2029 Common Stock 10,757 40.12 D
Stock Option (Right to Buy) (18) 02/18/2030 Common Stock 12,030 42.16 D
Explanation of Responses:
1. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
2. This amount represents the unvested portion of DSUs awarded on February 15, 2018, which will continue to vest in two remaining installments on the anniversary of the date of grant.
3. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
4. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
5. This amount represents the unvested portion of DSUs awarded on February 28, 2020, which will continue to vest in three remaining installments on the anniversary of the date of grant.
6. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
7. This amount represents the unvested portion of DSUs awarded on February 21, 2019, which will continue to vest in two remaining installments on the anniversary of the date of grant.
8. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
9. This amount represents the unvested portion of DSUs awarded on February 28, 2017, which will continue to vest in one remaining installment on the anniversary of the date of grant.
10. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on October 2, 2018, the first anniversary of the date of grant.
11. This amount represents the unvested portion of DSUs awarded on October 2, 2017, which will continue to vest in two remaining installments on the anniversary of the date of grant.
12. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
13. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
14. Grant to the reporting person of an option to purchase 18,037 shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
15. Grant to the reporting person of an option to purchase 15,006 shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
16. Grant to the reporting person of an option to purchase 14,299 shares of common stock vesting in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
17. Grant to the reporting person of an option to purchase 10,757 shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
18. Grant to the reporting person of an option to purchase 12,030 shares of common stock vesting in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
Remarks:
brownpoa.txt
/s/ Mai-Khoi Nguyen-Thanh, Attorney-in-Fact 06/17/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.